eFFECTOR Therapeutics, Inc.

EFTRDelisted Jul 19, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001828522

SEC filings (opens in a new tab)

eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of EFTR: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	18	19	+1
Shares	21.4M	22.5M	+1.07M (+5.0%)
Value	$174.2M	$89.7M	−$84.5M (−48.5%)

New holders (3)

Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to EFTR in Q1 2022
Institution	Shares	Value	% of portfolio
Parallel Advisors, LLC	677,452	$2.74M	0.11%
Norges Bank	416,300	$1.67M	0.00%
State Street Corp	17,000	$68.0K	0.00%

Sold out (2)

Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of EFTR in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Two Sigma Investments, LP	14,122	$117.0K
JPMorgan Chase & Co	780	$6.00K